comparemela.com

Latest Breaking News On - Health corporate contact - Page 5 : comparemela.com

DarioHealth Announces Participation in the Cowen 41st Annual Healthcare Conference

DarioHealth to Participate in 10th Annual SVB Leerink Global Healthcare Conference

DarioHealth Announces Acquisition of Leading Digital Musculoskeletal Company Upright Technologies and $70 Million Financing

DarioHealth Announces Acquisition of Leading Digital Musculoskeletal Company Upright Technologies and $70 Million Financing USA - English Expands DarioHealth s multi-condition platform into the $213 billion musculoskeletal market and creates one of the most comprehensive digital health platforms Financing supported by leading health care focused institutional investors, including Nantahala Capital Management, LLC, Perceptive Advisors, Driehaus Capital Management, Farallon Capital Management, Pura Vida Investments, and others priced at market pursuant to Nasdaq rules Increases membership to more than 150,000 and combined proforma 2020 full-year revenue to more than $20 million Company to host a conference call today, January 27, 2021, at 8:30 am ET News provided by Share this article

DarioHealth Announces Agreement with Presbyterian Medical Services for Remote Patient Monitoring

DarioHealth Announces Agreement with Presbyterian Medical Services for Remote Patient Monitoring USA - English Reflects ongoing momentum in Dario s shift in focus to B2B2C Selection follows rigorous RFP process News provided by Share this article Share this article NEW YORK, Dec. 22, 2020 /PRNewswire/ DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that the Company has entered into an agreement to provide its remote patient monitoring (RPM) solution to Presbyterian Medical Services, one of the largest integrated healthcare systems in the State of New Mexico, effective January 1, 2021. The selection of DarioHealth followed a rigorous request for proposal (RFP) process in which Dario s RPM solution was evaluated alongside several other digital therapeutics platforms.  

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.